Mouse CD38-Specific Heavy Chain Antibodies Inhibit CD38 GDPR-Cyclase Activity and Mediate Cytotoxicity Against Tumor Cells

CD38 is the major NAD(+)-hydrolyzing ecto-enzyme in most mammals. As a type II transmembrane protein, CD38 is also a promising target for the immunotherapy of multiple myeloma (MM). Nanobodies are single immunoglobulin variable domains from heavy chain antibodies that naturally occur in camelids. Us...

Descripción completa

Detalles Bibliográficos
Autores principales: Baum, Natalie, Eggers, Marie, Koenigsdorf, Julia, Menzel, Stephan, Hambach, Julia, Staehler, Tobias, Fliegert, Ralf, Kulow, Frederike, Adam, Gerhard, Haag, Friedrich, Bannas, Peter, Koch-Nolte, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446682/
https://www.ncbi.nlm.nih.gov/pubmed/34539634
http://dx.doi.org/10.3389/fimmu.2021.703574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446682/
https://www.ncbi.nlm.nih.gov/pubmed/34539634
http://dx.doi.org/10.3389/fimmu.2021.703574

Ejemplares similares